Renal Cell Carcinoma

Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
What is Renal Cell Carcinoma?

Renal cell carcinoma, also called hypernephroma, is a cancer of the kidneys that forms in the proximal convoluted tubule. In the UK, it is the eighth most common cancer among adults, affecting 9,300 people every year.

Read More

Overview

Feature Articles

Latest Renal Cell Carcinoma News and Research

New review examines link between HDLC and different types of cancer

New review examines link between HDLC and different types of cancer

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Recent therapeutic strategies for renal cell carcinoma and the effects of the tumor microenvironment on systemic therapy

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Two Cents' Worth: Shared decision making in renal cell carcinoma (RCC)

Cryoablation is more effective than heat-based treatment for some small kidney cancers

Cryoablation is more effective than heat-based treatment for some small kidney cancers

Triplet therapy slows progression of advanced kidney cancer

Triplet therapy slows progression of advanced kidney cancer

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

Study contributes to better understanding of the changes in kinase activity in renal cell carcinoma

Study uncovers how common genetic mutations cause renal cancer

Study uncovers how common genetic mutations cause renal cancer

Cytokine-based cancer immunotherapy: current progress and future prospects

Cytokine-based cancer immunotherapy: current progress and future prospects

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Moffitt researchers discover how YAP1 protein contributes to angiogenesis in cancers

Moffitt researchers discover how YAP1 protein contributes to angiogenesis in cancers

Study uncovers novel treatment for chromophobe renal cell carcinoma

Study uncovers novel treatment for chromophobe renal cell carcinoma

Conceptual framework to examine the patterns of copy number alterations in human cancer

Conceptual framework to examine the patterns of copy number alterations in human cancer

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Taking everolimus post-surgery can improve outcomes in patients with high-risk renal cell carcinoma

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Researchers illuminate the molecular landscape and clinical features of rare kidney cancer

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

Indication of minor added benefit of nivolumab for adjuvant treatment of esophageal cancer

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

SPORE-funded Kidney Cancer Program at UT Southwestern reports wide array of tumor models to date

Immune checkpoint inhibitor therapy results in longer treatment-free survival for patients with advanced renal cell carcinoma

Immune checkpoint inhibitor therapy results in longer treatment-free survival for patients with advanced renal cell carcinoma